RENOVORX, INC. (RNXT) Cash and securities
- Total cash · latest quarter (USD): Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities. Period ending 2026-06-30..
- Cash per share · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-06-30..
Cash and securities
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total cash · latest quarter (USD) | (m) | Cash and cash equivalents plus current marketable securities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Cash per share · latest quarter | (m) | Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash and equivalents | 9.48M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Marketable Securities, Current |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total cash | Cash per share | Cash and equivalents (USD) | Short-term securities (USD) | Quarter-end shares (shares) |
|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $9.48M | (m) | (m) |
| 2026-03-31 | (m) | (m) | $12.36M | (m) | (m) |
| 2025-12-31 | (m) | (m) | $7.02M | (m) | (m) |
| 2025-09-30 | (m) | (m) | $10.04M | (m) | (m) |
| 2025-06-30 | (m) | (m) | $12.31M | (m) | (m) |
| 2025-03-31 | (m) | (m) | $14.58M | (m) | (m) |
| 2024-12-31 | (m) | (m) | $7.15M | (m) | (m) |
| 2024-09-30 | (m) | (m) | $9.56M | (m) | (m) |
| 2024-06-30 | (m) | (m) | $11.74M | (m) | (m) |
| 2024-03-31 | (m) | (m) | $4.39M | (m) | (m) |
| 2023-12-31 | (m) | (m) | $1.17M | (m) | (m) |
| 2023-09-30 | (m) | (m) | $3.23M | (m) | (m) |
| 2023-06-30 | (m) | (m) | $5.95M | (m) | (m) |
| 2023-03-31 | (m) | (m) | $3.72M | (m) | (m) |
| 2022-12-31 | $6.44M | (m) | $4.39M | $2.05M | (m) |
| 2022-09-30 | $8.11M | (m) | $3.09M | $5.02M | (m) |
| 2022-06-30 | $10.77M | (m) | $2.77M | $8.00M | (m) |
| 2022-03-31 | (m) | (m) | $13.12M | (m) | (m) |
| 2021-12-31 | (m) | (m) | $15.19M | (m) | (m) |
| 2021-09-30 | (m) | (m) | $17.73M | (m) | (m) |
| 2020-12-31 | (m) | (m) | $1.79M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |